Aldeyra Therapeutics (ALDX) Payables (2013 - 2026)
Aldeyra Therapeutics (ALDX) recorded Payables of $137,476 in Q2 2026, down 90.6% from $1.46 million a year earlier and down 2.7% from the prior quarter.
Powered by 
Analysis
Aldeyra Therapeutics (ALDX) Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Aldeyra Therapeutics reported Payables of $158,461, down 12.2% from FY2024.
- Annual Payables has a five-year compound annual growth rate of -16.1% (FY2020 to FY2025).
- Across earlier years, Payables came in at $180,453 in FY2024 (-86.5%), $1.34 million in FY2023 (+901.4%), $133,625 in FY2022 (-86.9%) and $1.02 million in FY2021 (+167.2%).
- Quarterly Payables has ranged from $13,423 in Q3 2025 to $2.44 million in Q1 2022 over the past five years.
- On a year-over-year basis, Payables has declined for four consecutive quarters, with growth averaging 16.2% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 901.4% in Q4 2023, against a decline of 92.8% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $141,356 (Q1 2026), $158,461 (Q4 2025) and $13,423 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Aldeyra Therapeutics | 74.19 Mn | 74.19 Mn | - | 137,476.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 137,476.00 |
| Mar 31, 2026 | 141,356.00 |
| Dec 31, 2025 | 158,461.00 |
| Sep 30, 2025 | 13,423.00 |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 346,146.00 |
| Dec 31, 2024 | 180,453.00 |
| Sep 30, 2024 | 186,919.00 |
| Jun 30, 2024 | 254,434.00 |
| Mar 31, 2024 | 280,299.00 |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 247,194.00 |
| Jun 30, 2023 | 270,816.00 |
| Mar 31, 2023 | 429,685.00 |
| Dec 31, 2022 | 133,625.00 |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 264,225.00 |
| Mar 31, 2022 | 2.44 Mn |
| Dec 31, 2021 | 1.02 Mn |
| Sep 30, 2021 | 467,932.00 |
API Access
Aldeyra Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ALDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ALDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ALDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();